- Trials with a EudraCT protocol (44)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (9)
44 result(s) found for: Skull.
Displaying page 1 of 3.
EudraCT Number: 2022-000680-49 | Sponsor Protocol Number: MATRIx1.0 | Start Date*: 2022-12-13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE MONZA (ASST-MONZA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Mesenchymal stromal cells for traumatic brain injury. A multicenter, double blind, randomized, placebo-controlled phase II trial | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Severe traumatic brain injury | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: IT (Trial now transitioned) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003806-18 | Sponsor Protocol Number: IC2014-16 | Start Date*: 2016-03-24 |
Sponsor Name:INSTITUT CURIE | ||
Full Title: IMPROVEMENT OF LOCAL CONTROL IN SKULL BASE AND SPINE CHORDOMAS TREATED BY SURGERY AND PROTONTHERAPY TARGETING HYPOXIC CELLS REVEALED BY POSITRON EMISSION TOMOGRAPHY NITROIMIDAZOLE ([18F]FAZA) PET/C... | ||
Medical condition: Chordomas of the skull base, spine and sacrum | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-013056-71 | Sponsor Protocol Number: TC-2402-038-SP | Start Date*: 2010-03-10 | |||||||||||
Sponsor Name:Takeda Pharma A/S | |||||||||||||
Full Title: TachoSil versus current practice in dura sealing techniques for the prevention of post-operative cerebrospinal fluid (CSF) leaks in patients undergoing skull base surgery: An open label, randomised... | |||||||||||||
Medical condition: Skull base surgery for the prevention of postoperative cerebrospinal fluid (CSF) leaks | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) FI (Prematurely Ended) SE (Completed) DE (Completed) NL (Completed) GR (Completed) ES (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002620-17 | Sponsor Protocol Number: 18-513 | Start Date*: 2019-01-08 | |||||||||||
Sponsor Name:Portola Pharmaceuticals, Inc | |||||||||||||
Full Title: A PHASE 4 RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA [ANDEXANET ALFA FOR INJECTION] IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS RECEIVING AN ORAL FACTOR XA INHIBITOR | |||||||||||||
Medical condition: Oral FXa inhibitor-treated patients with acute intracranial bleeding. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) AT (Completed) BE (Completed) NL (Completed) ES (Prematurely Ended) GR (Completed) CZ (Completed) LV (Completed) FI (Prematurely Ended) NO (Prematurely Ended) LT (Prematurely Ended) PL (Completed) PT (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006089-14 | Sponsor Protocol Number: MIV-PK/PD-90255 | Start Date*: 2008-02-21 | |||||||||||
Sponsor Name:Neus Fabregas Julia - Hospital Clinic de Barcelona | |||||||||||||
Full Title: Farmacocinética y farmacodinámica del mivacurio en los pacientes tratados de forma crónica con anticomiciales | |||||||||||||
Medical condition: Anestesia en pacientes sometidos a neurocirugía | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003359-39 | Sponsor Protocol Number: ZEST | Start Date*: 2014-01-14 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Bisphosphonate Therapy with Zoledronic acid or Tenofovir Switching to Improve Low Bone Mineral Density in HIV-Infected Adults | |||||||||||||
Medical condition: low bone mineral density - HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004360-22 | Sponsor Protocol Number: Huntiam | Start Date*: 2021-10-22 | |||||||||||
Sponsor Name:Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (Ciberned) | |||||||||||||
Full Title: MULTI-TECHNICAL TEST ON THE USE OF COMBINED THERAPY OF THEMIN AND BIOTINE IN PATIENTS WITH HUNTINGTON'S DISEASE | |||||||||||||
Medical condition: Huntington´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002776-83 | Sponsor Protocol Number: Neuro-Ox-2018 | Start Date*: 2018-04-17 | |||||||||||
Sponsor Name:Bispebjerg Hospital | |||||||||||||
Full Title: Neuro-Ox-2018: Assessment of cerebral oxygenation under three clinically relevant conditions | |||||||||||||
Medical condition: Patients undergoing neurosurgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001974-76 | Sponsor Protocol Number: MK-3475-630 | Start Date*: 2019-01-16 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Adv... | |||||||||||||
Medical condition: Resectable high-risk locally advanced cutaneous squamous cell carcinoma (LA cSCC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Trial now transitioned) GB (GB - no longer in EU/EEA) DE (Trial now transitioned) FR (Trial now transitioned) PT (Trial now transitioned) HU (Trial now transitioned) ES (Ongoing) GR (Trial now transitioned) IE (Trial now transitioned) IT (Trial now transitioned) PL (Trial now transitioned) RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003072-39 | Sponsor Protocol Number: NTUH-AADC-011 | Start Date*: 2019-10-09 |
Sponsor Name:National Taiwan University Hospital | ||
Full Title: A Clinical Trial for Treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion | ||
Medical condition: Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2006-003381-33 | Sponsor Protocol Number: EMR-62202-717 | Start Date*: 2007-08-30 |
Sponsor Name:Institute of Oncology Ljubljana | ||
Full Title: Induction chemotherapy followed by chemoradiation with cetuximab and cisplatin for inoperable squamous cell carcinoma of the head and neck. | ||
Medical condition: Inoperable squamous cell carcinoma of the head and neck. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002978-39 | Sponsor Protocol Number: Ambulante_Geburtseinleitung | Start Date*: 2019-04-25 | |||||||||||
Sponsor Name:Medizinische Universität Graz | |||||||||||||
Full Title: Women's satisfaction with outpatient double-balloon catheter versus inpatient dinoprostone vaginal insert for induction of labour | |||||||||||||
Medical condition: Induction of labour | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004364-66 | Sponsor Protocol Number: BMR111-208 | Start Date*: 2019-10-22 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children with Achondroplasia | |||||||||||||
Medical condition: Achondroplasia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000392-14 | Sponsor Protocol Number: 1200.131 | Start Date*: 2011-07-27 | |||||||||||
Sponsor Name:Boehringer Ingelheim Limited | |||||||||||||
Full Title: LUX-Head & Neck 2 A randomised, double-blind, placebo-controlled, phase III study to evaluate the efficacy and safety of afatinib (BIBW 2992) as adjuvant therapy after chemoradiotherapy in primary... | |||||||||||||
Medical condition: Loco-regionally advanced head and neck squamous cell carcinoma with no evidence of disease after chemo-radiotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Prematurely Ended) BE (Completed) FR (Prematurely Ended) NL (Prematurely Ended) DE (Completed) FI (Prematurely Ended) GR (Prematurely Ended) AT (Prematurely Ended) SE (Prematurely Ended) IT (Completed) CZ (Prematurely Ended) DK (Prematurely Ended) PT (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002174-30 | Sponsor Protocol Number: B3D-US-GHCV | Start Date*: 2005-09-09 |
Sponsor Name:Eli Lilly and Company | ||
Full Title: The Use of Nuclear Scintigraphy to Evaluate the Anabolic Effects of Teriparatide on the Skeleton in Postmenopausal Women in Osteoporosis | ||
Medical condition: Oesteoporosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006913-26 | Sponsor Protocol Number: FLACC2008 | Start Date*: 2009-01-20 | ||||||||||||||||
Sponsor Name:Departement of orthopaedic surgery, Århus Sygehus | ||||||||||||||||||
Full Title: Postoperative smerter efter bækkenosteotomi med lokal infiltrationsanalgesi hos børn med cerebral parese. Et prospektivt, randomiseret og dobbeltblindet studie. | ||||||||||||||||||
Medical condition: cerebral parese | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003671-17 | Sponsor Protocol Number: NANOPRO | Start Date*: 2021-02-15 | |||||||||||
Sponsor Name:Centre François Baclesse | |||||||||||||
Full Title: Nanoparticle reirradiation and hypofractionated protontherapy of pan-tumor relapse: non-randomized phase II study. | |||||||||||||
Medical condition: recurrent tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000959-14 | Sponsor Protocol Number: 29BRC18.0262 | Start Date*: 2021-03-16 | |||||||||||||||||||||
Sponsor Name:CHRU de Brest | |||||||||||||||||||||||
Full Title: The NIPA study: A randomized double-blind control clinical trial Naloxegol administration to prevent opioids induced gastrointestinal motility disturbance in brain Injured PAtients. | |||||||||||||||||||||||
Medical condition: Prevent opioids induced gastrointestinal motility disturbance in brain Injured Patients. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002205-26 | Sponsor Protocol Number: FNUSA-2020-01 | Start Date*: 2020-06-18 | ||||||||||||||||
Sponsor Name:Fakultní nemocnice u sv. Anny v Brně | ||||||||||||||||||
Full Title: [68Ga] -SomaKIT-TOC PET / CT in postoperative evaluation of meningioma residues in the cranial base area | ||||||||||||||||||
Medical condition: evaluation of meningioma residues in the cranial base area | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001274-29 | Sponsor Protocol Number: CHUBX2017/46 | Start Date*: 2019-12-18 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Evaluation of the efficacy of intra-nasal sufentanil for analgesia of vaso-occlusive crisis in sickle-cell adults - | ||
Medical condition: Analgesia of vaso-occlusive crisis in sickle-cell adults | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
